
The civil aviation ministry has summoned Air India management over the August 4 Phuket-Delhi flight incident, sources told businessline. Senior officials pulled up the airline, with Aviation Secretary Samir Sinha warning that…
The civil aviation ministry has summoned Air India management over the August 4 Phuket-Delhi flight incident, sources told businessline. Senior officials pulled up the airline, with Aviation Secretary Samir Sinha warning that those found guilty will not be spared. The ministry has also ordered DGCA to review its drug testing framework, increase the percentage of personnel tested, and impose tougher penalties for positive results from recreational drugs while giving leeway to those whose tests stem from prescribed medicines.

The pilot-in-command of flight AI2379 is believed to have told investigators he was prescribed sleeping pills, which he claims led to two positive dope tests. Cabin crew filed a report saying the pilot was 'out of control', unable to walk, and that the co-pilot took charge. The aircraft suffered a 300-foot altitude drop and multiple hydraulic and system warnings, injuring 20 passengers and four crew. An Airbus team and France's BEA are assisting the investigation.

This incident risks being reduced to a lone pilot's failure. The real story has multiple strands: alleged pilot misconduct, a possible technical cascade of warnings, and a regulatory framework that treats a sleeping pill like a street drug. The pilot's defence of prescribed medication is not implausible, yet cabin crew describe someone unable to walk. Both can be true. The key test ahead is whether AAIB's probe separates spurious warnings from genuine system failures, and whether DGCA's revised rules distinguish legitimate medicine from abuse without punishing the former.
Sources (5): timesofindia.indiatimes.com, timesnownews.com, timesnownews.com (2), timesnownews.com (3), thehindubusinessline.com
This story was synthesised by AI from the 5 sources linked above.